Risk of hepatitis B virus reactivation in patients with autoimmune diseases undergoing non-tumor necrosis factor-targeted biologics

Hepatitis B virus reactivation (HBVr) can occur in patients treated with immunosuppressive medications. Risk stratification for HBVr based on hepatitis B virus (HBV) serology and viral load is an important strategy to determine appropriate HBV monitoring and antiviral prophylaxis use. Recent advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Shintaro, Cotter, Thomas G, Sakuraba, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130042/
https://www.ncbi.nlm.nih.gov/pubmed/34040324
http://dx.doi.org/10.3748/wjg.v27.i19.2312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130042/
https://www.ncbi.nlm.nih.gov/pubmed/34040324
http://dx.doi.org/10.3748/wjg.v27.i19.2312

Ejemplares similares